Guidance for industry : nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV), testing, product disposition, and donor deferral and reentry.

Bibliographic Details
Corporate Author:	Center for Biologics Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [2005]
Subjects:	Nucleic acids > Testing > United States. HIV (Viruses) > Diagnosis > United States. Hepatitis C virus > Diagnosis > United States. Blood donors > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS112841

Description
Item Description:	Title from PDF title page (viewed on May 19, 2009). "Draft guidance". "July 2005". Electronic resource.
Physical Description:	ii, 41 pages : digital, PDF file.
Format:	Mode of access: Internet at the FDA CBER web site. Address as of 5/19/09: http://www.fda.gov/cber/gdlns/nathivhcv.pdf ; current access is available via PURL.
Bibliography:	Includes bibliographical references (pages 24-25).